Note 12 - Revenue From Product Sales (Tables)

9 Months Ended

Sep. 30, 2025

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2025		2024		2025		2024
Jelmyto	$	25,703	$	25,204	$	70,172	$	65,833
Zusduri		1,779		—		1,779		—
Total Revenue	$	27,482	$	25,204	$	71,951	$	65,833

Schedule of Sales Reserves [Table Text Block]

	Reserves related to government sponsored programs			Medicare refunds for discarded drug reserve			Other reserves			Total accrued sales reserves
Balance as of December 31, 2024	$	887		$	7,729		$	1,946		$	10,562
Accruals		12,109			3,005			8,361			23,475
Utilizations		(10,787	)		(3,809	)		(8,042	)		(22,638	)
Changes to prior period estimates		—			(414	)		—			(414	)
Balance as of September 30, 2025	$	2,209		$	6,511		$	2,265		$	10,985
Balance as of December 31, 2023	$	1,062		$	3,451		$	1,458		$	5,971
Accruals		9,833			3,113			7,703			20,649
Utilizations		(10,206	)		—			(7,219	)		(17,425	)
Balance as of September 30, 2024	$	689		$	6,564		$	1,942		$	9,195